Dear Team Members, Healthcare Providers, Patients, and all Stakeholders of CDI: You are valued and appreciated. This is the first and most important message I want to send. As I reflect on 2022 and look ahead to 2023, I’m deeply grateful for the diverse group of partners working together to ensure the collective health of…
CDI’s President & CEO Craig Strasnick was recently interviewed for The Root Cause Medicine Podcast. During the episode, Strasnick discusses small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) and how the diagnostic side of GI disturbances provides important data that helps guide research and the development of therapies to help patients find relief.…
Collaboration will accelerate and streamline gastroenterology (GI) clinical trials with an end-to-end platform for patient recruitment, enrollment, and management Salem, Mass. and Fremont, Calif. – October 20, 2022 – My Total Health Inc., in partnership with Commonwealth Diagnostics International, Inc. (CDI), announced today a strategic partnership with CliniOps in which the companies will collaborate…
Sulfate-reducing bacteria (SRB) in the gut produce Hydrogen Sulfide (H2S) internally and externally in humans. H2S plays an essential role in the control of vascular homeostasis, and ongoing studies have shown that extreme levels of SRB in the gut may cause small intestinal bacterial overgrowth (SIBO). Gastrointestinal disorders such as irritable bowel syndrome, ulcerative colitis,…
CDI’s President & CEO Craig Strasnick was recently interviewed for the GI StartUp Podcast about life as a healthcare entrepreneur and the origins of CDI. Listen as Craig also speaks about functional GI disorders, breath testing, digital health, and the decentralization of medical testing. The podcast episode is available on Apple Podcasts, Spotify, Google Podcasts,…
Commonwealth Diagnostics International, Inc. (CDI), an innovative GI health company providing industry-leading diagnostic tests and tools to help physicians identify and diagnose common sources of digestive distress and functional gastrointestinal ailments, today announced expanded access to the naturopathic and integrative medicine community through a strategic partnership with Rupa Health, a digital health platform making it…
Salem, Mass. – August 11, 2022 – Commonwealth Diagnostics International, Inc. (CDI), an innovative GI health company providing industry-leading diagnostic tests and tools to help physicians identify and diagnose common sources of digestive distress and functional gastrointestinal ailments, is proud to be recognized as one of the Top 100 Healthcare Technology Companies of 2022 by…
The second issue of Modern Gastro presented by CDI featuring the latest functional gastrointestinal (GI) trends and insights is now available in digital format. Featured articles in the Q3 2022 issue of Modern Gastro include: Mid-Year Update from CDI’s President & CEO Industry Insights from recent GI Community Discussions Highlights from the Mid-Year 2022 Functional…
Commonwealth Diagnostics International Inc. (CDI) is proud to announce that the first release of Modern Gastro is now available in digital format. The magazine, also distributed complimentary in print format to select gastroenterologists nationwide, features functional gastrointestinal (GI) trends and insights. Featured articles in the inaugural issue of Modern Gastro include: Highlights from the 2021…
To our Team Members, Healthcare Community Partners, and Friends of CDI: 2021 was an informative year. The world continues to navigate a new and ever-changing set of circumstances caused by a global health pandemic. While it’s clear that we’ve made meaningful progress at the worldwide level to diminish the rampant effects of this virus, it’s…
